The role of nebulized inhaled corticosteroid therapy in adult patients with asthma and chronic obstructive pulmonary disease

Advances in Therapy

Volumn 22, Issue 4, 2005, Pages 407-418

  Marcus, Philip ^a,b,c  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b ST FRANCIS HOSPITAL   (United States)

^c Nassau Chest Physicians PC   (United States)

Author keywords

Asthma; COPD; Inhaled corticosteroids; Nebulized ICS therapy

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; HYDROCORTISONE; IPRATROPIUM BROMIDE; LEVALBUTEROL; OSTEOCALCIN; PREDNISOLONE; SALBUTAMOL;

ASTHMA; CATARACT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRY POWDER; FETOTOXICITY; HUMAN; INHALATION; METERED DOSE INHALER; NEBULIZATION; REVIEW;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; ASTHMA; GLUCOCORTICOIDS; HUMANS; NEBULIZERS AND VAPORIZERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 29344435529     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850087     Document Type: Review

References (38)

1. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma. Update on selected topics-2002. J Allergy Clin Immunol. 2002;110(5 suppl):S141-S219.
2. Global Initiative for Chronic Obstructive Lung Disease™. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Executive Summary. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 2003.
3. American Thoracic Society. Management of Stable COPD: Pharmacological Therapy. Available at: http://www.thoracic.org/COPD/6/glucocorticoids.asp. Accessed on: August 23, 2004.
4. Allen SC, Jain M, Ragab S, Malik N. Acquisition and short-term retention of inhaler techniques requiring intact executive function in elderly subjects. Age Ageing. 2003;32:299-302.
5. Gray SL, Williams DM, Pulliam CC, Sirgo MA, Bishop AL, Donohue JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med. 1996;156:984-988.
6. O'Donohue WJ and the National Association for Medical Direction of Respiratory Care Consensus Group. Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. Chest. 1996;109:814-820.
7. Demoly P, Jaffuel D, Sahla H, Bousquet J, Michel F-B, Godard P. The use of home nebulizers in adult asthma. Respir Med. 1998;92:624-627.
8. Dahlström K, Thorson L, Larsson P, Nikander K. Systematic availability and lung deposition of budesonide via three different nebulizers in adults. Ann Allergy Asthma Immunol. 2003;90: 226-232.
9. Szefler SJ, Eigen H. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma. J Allergy Clin Immunol. 2002;109:730-742.
10. Pulmicort Turbuhaler® [package insert]. Wilmington, Del: AstraZeneca LP; September 2004.
11. Edsbacker S, Brattsand R. Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data. Ann Allergy Asthma Immunol. 2002;88:609-616.
12. Pulmicort Respules® [package insert]. Wilmington, Del: AstraZeneca LP; September 2004.
13. Flixotide™ Nebules™ [package insert]. Uxbridge, Middlesex, UK: Glaxo Wellcome UK Ltd; March 2003.
14. Dempsey OJ, Humphreys M, Coutie WJR, Lipworth BJ. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers. Eur J Clin Pharmacol. 2001;57:637-641.
15. Connolly KC, Peake PD, Halpin DMG, Golightly L, Turbitt ML. Challenging current asthma treatment guidelines. Improved control of asthma symptoms with nebulized budesonide in patients with severe asthma receiving continuous oral steroids. Dis Manag Health Outcomes. 2000;7:217-225.
16. Otulana BA, Varma N, Bullock A, Higenbottam T. High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Respir Med. 1992;86:105-108.
17. Higenbottam TW, Clark RA, Luksza AR, et al. The role of nebulized budesonide in permitting a reduction in the dose of oral steroid in persistent severe asthma. Eur J Clin Res. 1994;5:1-10.
18. O'Connor BJ, Barsan GS, O'Connell F, O'Shaughnessy KM. Oral steroid sparing effect of nebulized budesonide in chronic severe asthma. Am J Respir Crit Care Med. 1996;153:A341.
19. Westbroek J, Saarelainen S, Laher M, O'Brien J, Barnacle H, Efthimiou J. Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma. Respir Med. 1999;93:689-699.
20. Gawchik SM. Successful treatment of previously uncontrolled adult asthma with budesonide inhalation suspension (Pulmicort Respules®) [abstract]. Ann Allergy Asthma Immunol. 2002;88:97. Abstract 75.
21. Berman GD, Rockey C. Nebulized budesonide inhalation suspension (Pulmicort Respules®) improves asthma control and quality of life in an adult cerebral palsy patient unable to use metered-dose inhalers [abstract]. Ann Allergy Asthma Immunol. 2003;90:103. Abstract 26.
22. Higenbottam TW, Britton J, Lawrence D, et al, on behalf of the Pulmicort Respules Versus Oral Steroids: A Prospective Clinical Trial in Acute Asthma (PROSPECTS): ADULT study team. Comparison of nebulized budesonide and prednisolone in severe asthma exacerbations in adults. Bio Drugs. 2000;14:247-254.
23. Morice AH, Morris D, Lawson-Matthew P. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clin Pharmacol Ther. 1996;60:675-678.
24. Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;165:698-703.
25. Sharma PK, Malhotra S, Pandhi P, Kumar N. Effect of inhaled steroids on bone mineral density: a meta-analysis. J Clin Pharmacol. 2003;43:193-197.
26. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G. Inhaled corticosteroid effect on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002; CD003537.
27. Richy F, Bousquet J, Ehrlich GE, et al. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int. 2003;14:179-190.
28. Wilson AM, McFarlane LC, Lipworth BJ. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics. Chest. 1998;114:1022-1027.
29. Cruz-Rivera M, Lyzell E, Fitzpatrick S. Low frequency of adverse events reported through postmarketing surveillance for Pulmicort Respules® (budesonide inhalation suspension) in the US adult population [abstract]. J Allergy Clin Immunol. 2002;109(suppl):S292. Abstract 895.
30. Lyzell E, Cruz-Rivera M, Fitzpatrick S. Safety of Pulmicort Respules® (budesonide inhalation suspension) in geriatric patients: postmarketing surveillance and clinical study data [abstract]. J Allergy Clin Immunol. 2002;109(suppl):S292. Abstract 894.
31. Källén B, Rydhstroem H, Åberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93:392-395.
32. Ericson A, Källén B. Use of drugs during pregnancy-unique Swedish registration method that can be improved. Information From the Swedish Medical Products Agency. 1999;1:8-11.
33. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis. 1993;148:S1-S26.
34. Nikander K, Turpeinen M, Wollmer P. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J Aerosol Med. 1999;12:47-53.
35. Smaldone GC, Crus-Rivera M, Nikander K. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med. 1998;11:113-125.
36. Barry PW, O'Callaghan C. An in vitro analysis of the output of budesonide from different nebulizers. J Allergy Clin Immunol. 1999;104:1168-1173.
37. Bisgaard H, Nikander K, Munch E. Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics. Respir Med. 1998;92:44-49.
38. McKenzie JE, Cruz-Rivera M. Compatibility of budesonide inhalation suspension with four nebulizing solutions. Ann Pharmacother. 2004;38:967-972.